News
PepsiCo and Coca-Cola face demand headwinds, tariff risks, and high debt, but PEP stands out with value upside and dividends.
StockStory.org on MSN2d
Coca-Cola Earnings: What To Look For From KOBeverage company Coca-Cola (NYSE:KO) will be announcing earnings results this Tuesday before market open. Here’s what to ...
Analysts currently favor an Neutral trajectory for PepsiCo, with an average 1-year price target of $150.88, suggesting a potential 116.01% upside. Analysts currently favor an Outperform trajectory for ...
Here are three things Wall Street is watching on Tuesday, July 22. The S&P 500 (^GSPC) and the Nasdaq Composite (^IXIC) ended Monday's trading session at record highs. General Motors (GM) reports ...
Coca-Cola stock has traded sideways most summer, but is the 12th-best Dow name this year, up 11.9% year-to-date. The shares have support in place at their 200-day moving average, though overhead there ...
PepsiCo’s stock jumped 7% on July 17 after a robust Q2 earnings announcement. The company not only surpassed expectations but ...
Highlighted opportunities include NANO Nuclear Energy's niche potential, Christian Dior SE's LVMH exposure, and Harrow's ...
The VUD indicator, the most sensitive measure of supply and demand in real time, did not turn orange even when the stock market was rapidly dropping. Orange indicates a net supply of stocks, and green ...
StockStory.org on MSN7h
Movado (MOV) Stock Trades Up, Here Is WhyShares of luxury watch company Movado (NYSE:MOV) jumped 3.2% in the afternoon session after a broad market rally as the United States and Japan reached a new trade agreement. The deal, which set a 15% ...
Shares of mortgage servicing company Mr. Cooper Group (NASDAQ:COOP) jumped 3.4% in the morning session after an analyst at ...
StockStory.org on MSN9h
Why Dynatrace (DT) Stock Is Trading Up TodayWhat Happened? Shares of application performance monitoring software provider Dynatrace (NYSE:DT) jumped 3.2% in the ...
StockStory.org on MSN9h
Medpace (MEDP) Stock Trades Down, Here Is WhyWhat Happened? Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 7.5% in the afternoon session after an analyst at TD Cowen downgraded the stock to "Sell" from "Hold," citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results